GlassScriptPhysician profile
Pampee P Young
NPI 1699859702
$52,704.21
in general payments reported to CMS, 2019-2025
7 companies · $3,763 in 2025
The $3,763 reported for 2025 was more than what 93% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,562 · 2021: $7,727 · 2022: $7,542 · 2023: $11K · 2024: $8,104 · 2025: $3,763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Honoraria: $3,500 · Consulting Fee: $3,500 · Food and Beverage: $1,956 · Gift: $62.06 · Entertainment: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $13,616.71 |
| Honoraria | $3,500.00 |
| Consulting Fee | $3,500.00 |
| Food and Beverage | $1,955.78 |
| Gift | $62.06 |
| Entertainment | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerus Corporation | $23,633.16 | 2020-2025 | Intercept Blood System For Platelets, Intercept Blood System For Cryoprecipitation |
| Fresenius Kabi USA, LLC | $22,700.37 | 2019-2024 | Amicus Separator |
| Ortho-Clinical Diagnostics, INC. | $3,400.00 | 2021 | |
| Roche Molecular Systems, INC. | $1,500.00 | 2019 | |
| Terumo Bct, INC. | $879.16 | 2020-2024 | Spectra Optia, Trima Accel |
| Roche Diagnostics Corporation | $525.00 | 2021 | |
| Grifols Diagnostic Solutions, INC. | $66.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pampee Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.